Tech Company Financing Transactions

N30 Pharmaceuticals Funding Round

Deerfield Capital, Jennison Associates and RA Capital joined a $20 million funding round for N30 Pharmaceuticals. The round closed on 11/20/2014.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Proceeds Purpose
Proceeds from the financing will primarily be used to advance the Company's clinical trial program for N91115, a novel inhibitor S-nitrosoglutathione reluctase (GSNOR).

Company Information

Company Status
Private & Independent
Mailing Address
3122 Sterling Cir. 200
Boulder, CO 80301
Email Address
N30 Pharmaceuticals, LLC is developing s-nitrosothiol therapies for important unmet needs in respiratory diseases. N30's strategy focuses on administration of GSNO to the human airway, and development of small molecule inhibitors of GSNO reductase.
N30 Pharmaceuticals LinkedIn Company Profile
Social Media
N30 Pharmaceuticals Company Twitter Account
Company News
N30 Pharmaceuticals News
N30 Pharmaceuticals on Facebook
N30 Pharmaceuticals on YouTube

Management Team

Email & Social
Chief Executive Officer
Jon Congleton
  Jon Congleton LinkedIn Profile  Jon Congleton Twitter Account  Jon Congleton News  Jon Congleton on Facebook
Chief Financial Officer
Tom Sokolowski
  Tom Sokolowski LinkedIn Profile  Tom Sokolowski Twitter Account  Tom Sokolowski News  Tom Sokolowski on Facebook
VP - R & D
Sherif Gabriel
  Sherif Gabriel LinkedIn Profile  Sherif Gabriel Twitter Account  Sherif Gabriel News  Sherif Gabriel on Facebook
VP - Regulatory Affairs
Janice Troha
  Janice Troha LinkedIn Profile  Janice Troha Twitter Account  Janice Troha News  Janice Troha on Facebook



Browse more venture capital transactions:

Prev: 11/20/2014: Flashback Technologies venture capital transaction
Next: 11/20/2014: Cue venture capital transaction


Share this article


About Our VC Transactions Data

We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary